Stability of Ophthalmic Atropine Solutions for Child Myopia Control
Myopia is an ophthalmic condition affecting more than 1/5th of the world population, especially children. Low-dose atropine eyedrops have been shown to limit myopia evolution during treatment. However, there are currently no commercial industrial forms available and there is little data published co...
Main Authors: | Baptiste Berton, Philip Chennell, Mouloud Yessaad, Yassine Bouattour, Mireille Jouannet, Mathieu Wasiak, Valérie Sautou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/8/781 |
Similar Items
-
Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases
by: Marion Barrieu, et al.
Published: (2022-01-01) -
Stability of an ophthalmic formulation of polyhexamethylene biguanide in gamma-sterilized and ethylene oxide sterilized low density polyethylene multidose eyedroppers
by: Yassine Bouattour, et al.
Published: (2018-04-01) -
Long term physicochemical stability study of novel ophthalmic formulations combining ceftazidime and vancomycin with and without cyclodextrins
by: Plaidy Pauline, et al.
Published: (2023-09-01) -
Atropine in the treatment of childhood myopia
by: Sanitha Sathyan
Published: (2019-01-01) -
Cyclodextrins Allow the Combination of Incompatible Vancomycin and Ceftazidime into an Ophthalmic Formulation for the Treatment of Bacterial Keratitis
by: Yassine Bouattour, et al.
Published: (2021-09-01)